Atopic Dermatitis Market Size to Grow at Stellar CAGR of 24%, Surpassing US$ 62.7 Billion by 2032

Published April 23, 2023

In 2021 and 2022, respectively, the market for atopic dermatitis will be worth US$5.9 billion and US$7.3 billion. With a value CAGR of 24% between 2022 and 2032, demand is projected to rise, potentially reaching US$ 62.7 billion by the end of the assessment period.

In the next years, it is anticipated that the rise of cutting-edge medical technology and the introduction of fresh techniques would drive the expansion of the atopic dermatitis market.

Download Sample Copy of This Report:

Atopic Dermatitis Market Scope:

Report Coverage Details
Forecast Period 2022-2032
Forecast Period 2022 to 2032 CAGR 24%
2032 Value Projection US$ 62.7 Billion
US Growth Rate ~ 27%
Historical Data for 2017-2021
No. of Pages 170
Segments covered By Type, End-user, and Region

Which Emerging Trends Are Driving Demand for Atopic Dermatitis?

Development of Novel Drugs to Accelerate Market Growth

There are many different types of dermatological illnesses that are very common all over the world. The World Health Organisation estimates that more than 900 million people experienced skin conditions in 2017. Atopic dermatitis is one of these illnesses that affects more than 300 million individuals worldwide.

Children make up roughly one-fifth of the victims. The atopic dermatitis market is anticipated to rise in the near future as a result of the disease’s rising occurrence.

Other factors are also anticipated to increase the need for atopic dermatitis medications, including the creation of novel pipeline therapies, growing demand for new biologics, and product approvals.

Key Players

  • Mylan M.V.
  • Pfizer Inc.
  • LEO Pharma A/S
  • Teva Pharmaceutical Industries Ltd
  • Sanofi
  • Novartis AG.

How Retail Pharmacies to be Lucrative Revenue Pockets of Global Atopic Dermatitis Market?

The most successful distribution strategy is predicted to be through retail pharmacies. Nearly 45% of the global market for atopic dermatitis is predicted to be accounted for by this segment.

The primary growth drivers for this market sector are the accessibility of small molecule drugs and the expansion of retail pharmacies globally.

Some important factors fostering the market’s expansion include affordability, convenience, and the straightforward availability of therapeutic medications at the desired location. Retail pharmacies are expected to grow at a CAGR of 27.4% over the course of the projection period.

Along with the primary growth factors, this research also considers classification, engagement, applications, and market trends. Additionally, this research analyses opportunities and difficulties in the Atopic Dermatitis market and focuses on emerging trends.

Our experts’ thorough analysis of CAGR and market size aims to provide a precise picture of the market. This study is overly extensive and helpful for preserving a competitive edge over others because it covers recent developments and the competitive landscape.

The key business strategies discussed in this market research revolve around-

1) How key market players are maintaining their competitive advantage in the wake of globalization?
2) What changing dynamics in the Atopic Dermatitis market specify about the future opportunities for manufacturers?
3) How Covid-19 pandemic affected sales and what strategies are expected to recover from its impact?
4) What business tactics are gaining attention and influencing Atopic Dermatitis industry rivalry?

Get Customization on this Report:

Key Highlights of the Research Report:

– The study examines how the global Atopic Dermatitis market would be influenced by strict pollution control regulations.
– To look at the competition from different angles using Porter’s five forces research.
– To study the product type that is expected to dominate the market is the subject of research.
– To examine the regions those are projected to expand the most rapidly during the forecast era.
– To identify the big Atopic Dermatitis market players’ new trends, market positions, and strategies.
– To study value chain analysis and overview of the positions of various stakeholders.

Global Atopic Dermatitis Market Segmentation

  • By Drug Class :
    • Corticosteroids
    • PDE4 Inhibitors
    • Biologics
    • Skin Barrier Emollients
    • CNI Immunosuppressants
    • Others
  • By Distribution Channel :
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • By Key Regions :
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa

Get Full Access of Complete Report:

The study will be used by consumers to draw a fair conclusion and take into account existing and upcoming opportunities and advancements in the global Atopic Dermatitis market. The report also examines contemporary businesses that are upending the market with their cutting-edge innovations and technologies.

The study provides in-depth analysis of recent trends in revenue for the forecasted term. Based on fundamental dynamics and growth-promoting factors, this research study evaluates the market valuation for Atopic Dermatitis and the rate of progress. Report preparation requires knowledge of recent industry events, prospects, and significant inventions.

Atopic Dermatitis Market Relevant Questions Answered in the Report Are:

– What are the best investment choices for venturing into the Atopic Dermatitis market?
– What regulations are implied by the governments for the stakeholders?
– Which are the maturing segments in the Atopic Dermatitis market that may see considerable growth in the market?
– Which strategies the vendors should adopt for cost-optimization?
– What are the socio-economic and political trends influencing the Atopic Dermatitis industry?
– What are the valuable opportunities in the Atopic Dermatitis market?
– What are the entry barriers to the new players?

Check out more related studies published by Fact.MR Research:


US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States

This Press Release has been written with the intention of providing accurate market information which will enable our readers to make informed strategic investment decisions. If you notice any problem with this content, please feel free to reach us on


Xherald is passionate about offering extensive coverage of global business news. Dedicated to creating every participant's notification, it reaches its own reader. Daily our experts offer fresh relevant information regarding what is actually occurring in Markets as well as Business. Our headlines are actually swiftly paced and extensive. Our distributor directory connects you with brand new products or services and its market situation from the most effective companies around the planet. Xherald is driven by its 500+ contributors coming from around the world. Xherald provides local as well as global market intelligence information coverage in sectors ranging from healthcare, IOT, chemicals and 17 more sectors. Our updates are quickly paced and detailed. The news we present is actually a mix of authentic content, community contributions and curated headlines announcements. All of the updates our company supplies must pass a strict criterion of genuineness, relevance and significance to our readers.